Skip to main content

Table 1 Demographic and laboratory data of studied groups

From: Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Parameter HCC group (n=40) LC group (n=20) p
Age (years) 57.1±6.8 54.8±7.6 0.236
BMI (Kg/m2) 24.7±2.1 25.4±3 0.365
Gender Male n (%) 28 (70%) 12 (60%) 0.439
Female n (%) 12 (30%) 8 (40%)
Child-Pugh class A n (%) 23 (57.5%) 9 (45%) 0.305
B n (%) 17 (42.5%) 10 (50%)
C n (%) 0 (0.0%) 1 (5%)
ALT (U/L) 57.0±28.3 40.2±17.3 0.006
AST (U/L) 57.9±31.0 30.9±17.1 < 0.001
ALP (U/L) 79.2±23.6 88.4±30.7 0.25
S. albumin (g/dl) 3.6±0.4 3.4±0.6 0.156
T. bilirubin (mg/dl) 1.5±0.4 1.7±0.6 0.13
D. bilirubin (mg/dl) 0.7±0.2 0.9±0.4 0.117
INR 1.4±0.38 1.31±0.37 0.37
Hemoglobin (g/dL) 11.0±1.5 10.3±0.9 0.022
WBCs (× 103/mL) 7±2.3 5.6±1.4 0.28
Platelets (× 103/mL) 148.0±36.5 137.4±41 0.313
S. creatinine (mg/dL) 0.85±0.32 0.79±0.32 0.516
S. sodium (mEq/L) 137.6±3.8 136.3±3.1 0.187
S. potassium (mEq/L) 4.0±0.5 4.2±0.4 0.129